{"title":"Projects","markdown":{"yaml":{"title":"Projects"},"headingText":"Quantifying Secondhand Aerosol Exposure to HCWs During Nebulization","containsRefs":false,"markdown":"\n<br>\n\nHere are some of the projects I've worked on. \n\n---\n\n\n- **Skills**: Bench modeling, UV spectroscopic, SPSS, Graph Pad Prism, study design.\n\n- **Date**: September, 2025\n\n- **Link**: <https://shorturl.at/hg5TX>\n\n![](images/project1.png)\n\n### Overview\nIn a climate-controlled ICU room, we quantified inhaled dose and ambient particle concentrations to estimate health-care worker (HCW) exposure to fugitive aerosols during nebulization.\n\n### Methods\n- Set-up: Patient + two HCW adult airway models at 1 ft and 3 ft; ventilator-driven spontaneous breathing.\n- Interface: Aerosol mask (mouth-breathing), tracheostomy mask, T-piece.\n- Drug Delivery: Albuterol via jet nebulizer (2 sessions; 30 mg total over 30 minutes).\n- Measurements: Inhaled drug on filters (UV at 276 nm), continuous particle counts at both distances; repeated trials with 30-min room reset.\n\n### Key Results\n- HCW inhaled dose ~0.1–0.3% of nominal across interfaces/distances; highest with trach mask.\n- Higher particle concentration at 1 ft than 3 ft for trach mask; strong linear correlation between inhaled dose and 1-ft aerosol levels (r²≈0.79).\n- Findings suggest low but non-negligible exposure; call for in-vivo/long-term risk assessment.\n\n---\n\n## Prophylactic Inhaled Antibiotics to Prevent VAP: Systematic Review & Network Meta-analysis\n\n- **Skills**: Evidence synthesis, R (meta/netmeta/gemtc), GRADE, trial sequential analysis.\n\n- **Date**: May, 2024 \n\n- **Link**: <https://shorturl.at/sxMGb>\n\n![](images/project2.png)\n\n### Overview\nComprehensive review of inhaled/instilled antibiotics for VAP prevention in adults on invasive ventilation ≥48 h; emphasis on nebulized delivery.\n\n### Methods\n- Databases: PubMed, Scopus, Cochrane, ClinicalTrials.gov (to Oct 25, 2023).\n- 7 RCTs (n=1445) primary analyses (plus sensitivity with observational).\n- Random-effects meta-analysis; network meta-analysis for drug/route ranking; GRADE and TSA for certainty\n\n### Key Results\n- Prophylactic respiratory-tract antibiotics reduced VAP risk (RR≈0.69).\n- Nebulization and aminoglycosides showed the strongest signal (e.g., RR≈0.64 for nebulization).\n- No clear differences in mortality, MV duration, LOS, or adverse events vs. control.\n\n---\n\n## The effects of flow settings during high-flow nasal cannula support for adult subjects: a systematic review\n\n- **Skills**: Systematic review and physiology synthesis. \n\n- **Date**: February, 2023\n\n- **Link**: <https://shorturl.at/BfAwB>\n\n![](images/project3.png)\n\n### Overview\nA systematic review of in vitro and in vivo studies examining how HFNC flow rates influence oxygenation, work of breathing, and comfort—and how to personalize flow titration.\n\n### Methods\n- Comprehensive search and synthesis of 44 studies (bench + adult human).\n- Extraction of key physiologic parameters: FiO₂ stability, PEEP, CO₂ washout, PTIF, comfort, and ROX index.\n- Critical appraisal and integration of quantitative and qualitative data.\n\n### Key Results\n\n- Optimal performance achieved when flow ≥ patient PTIF, improving FiO₂ stability and PEEP.\n- Mouth status (open vs. closed) significantly affects pressure generation.\n- Very high flows may cause regional over-distension or discomfort; individualized titration is essential.\n---\n\n## Ongoing Projects\n\n### Timely Treatment Escalation After Recurrent Asthma Exacerbations\n\n- Multi-center EHR study to identify adults with recurrent asthma exacerbation, quantify how often guideline-recommended escalation occurs within 90 days, and evaluate whether escalation prolongs time to the next exacerbation.\n\n---\n\n*Interested in collaborating? Feel free to reach out!*\n","srcMarkdownNoYaml":"\n<br>\n\nHere are some of the projects I've worked on. \n\n---\n\n## Quantifying Secondhand Aerosol Exposure to HCWs During Nebulization\n\n- **Skills**: Bench modeling, UV spectroscopic, SPSS, Graph Pad Prism, study design.\n\n- **Date**: September, 2025\n\n- **Link**: <https://shorturl.at/hg5TX>\n\n![](images/project1.png)\n\n### Overview\nIn a climate-controlled ICU room, we quantified inhaled dose and ambient particle concentrations to estimate health-care worker (HCW) exposure to fugitive aerosols during nebulization.\n\n### Methods\n- Set-up: Patient + two HCW adult airway models at 1 ft and 3 ft; ventilator-driven spontaneous breathing.\n- Interface: Aerosol mask (mouth-breathing), tracheostomy mask, T-piece.\n- Drug Delivery: Albuterol via jet nebulizer (2 sessions; 30 mg total over 30 minutes).\n- Measurements: Inhaled drug on filters (UV at 276 nm), continuous particle counts at both distances; repeated trials with 30-min room reset.\n\n### Key Results\n- HCW inhaled dose ~0.1–0.3% of nominal across interfaces/distances; highest with trach mask.\n- Higher particle concentration at 1 ft than 3 ft for trach mask; strong linear correlation between inhaled dose and 1-ft aerosol levels (r²≈0.79).\n- Findings suggest low but non-negligible exposure; call for in-vivo/long-term risk assessment.\n\n---\n\n## Prophylactic Inhaled Antibiotics to Prevent VAP: Systematic Review & Network Meta-analysis\n\n- **Skills**: Evidence synthesis, R (meta/netmeta/gemtc), GRADE, trial sequential analysis.\n\n- **Date**: May, 2024 \n\n- **Link**: <https://shorturl.at/sxMGb>\n\n![](images/project2.png)\n\n### Overview\nComprehensive review of inhaled/instilled antibiotics for VAP prevention in adults on invasive ventilation ≥48 h; emphasis on nebulized delivery.\n\n### Methods\n- Databases: PubMed, Scopus, Cochrane, ClinicalTrials.gov (to Oct 25, 2023).\n- 7 RCTs (n=1445) primary analyses (plus sensitivity with observational).\n- Random-effects meta-analysis; network meta-analysis for drug/route ranking; GRADE and TSA for certainty\n\n### Key Results\n- Prophylactic respiratory-tract antibiotics reduced VAP risk (RR≈0.69).\n- Nebulization and aminoglycosides showed the strongest signal (e.g., RR≈0.64 for nebulization).\n- No clear differences in mortality, MV duration, LOS, or adverse events vs. control.\n\n---\n\n## The effects of flow settings during high-flow nasal cannula support for adult subjects: a systematic review\n\n- **Skills**: Systematic review and physiology synthesis. \n\n- **Date**: February, 2023\n\n- **Link**: <https://shorturl.at/BfAwB>\n\n![](images/project3.png)\n\n### Overview\nA systematic review of in vitro and in vivo studies examining how HFNC flow rates influence oxygenation, work of breathing, and comfort—and how to personalize flow titration.\n\n### Methods\n- Comprehensive search and synthesis of 44 studies (bench + adult human).\n- Extraction of key physiologic parameters: FiO₂ stability, PEEP, CO₂ washout, PTIF, comfort, and ROX index.\n- Critical appraisal and integration of quantitative and qualitative data.\n\n### Key Results\n\n- Optimal performance achieved when flow ≥ patient PTIF, improving FiO₂ stability and PEEP.\n- Mouth status (open vs. closed) significantly affects pressure generation.\n- Very high flows may cause regional over-distension or discomfort; individualized titration is essential.\n---\n\n## Ongoing Projects\n\n### Timely Treatment Escalation After Recurrent Asthma Exacerbations\n\n- Multi-center EHR study to identify adults with recurrent asthma exacerbation, quantify how often guideline-recommended escalation occurs within 90 days, and evaluate whether escalation prolongs time to the next exacerbation.\n\n---\n\n*Interested in collaborating? Feel free to reach out!*\n"},"formats":{"html":{"identifier":{"display-name":"HTML","target-format":"html","base-format":"html"},"execute":{"fig-width":7,"fig-height":5,"fig-format":"retina","fig-dpi":96,"df-print":"default","error":false,"eval":true,"cache":null,"freeze":false,"echo":true,"output":true,"warning":true,"include":true,"keep-md":false,"keep-ipynb":false,"ipynb":null,"enabled":null,"daemon":null,"daemon-restart":false,"debug":false,"ipynb-filters":[],"ipynb-shell-interactivity":null,"plotly-connected":true,"engine":"markdown"},"render":{"keep-tex":false,"keep-typ":false,"keep-source":false,"keep-hidden":false,"prefer-html":false,"output-divs":true,"output-ext":"html","fig-align":"default","fig-pos":null,"fig-env":null,"code-fold":"none","code-overflow":"scroll","code-link":false,"code-line-numbers":false,"code-tools":false,"tbl-colwidths":"auto","merge-includes":true,"inline-includes":false,"preserve-yaml":false,"latex-auto-mk":true,"latex-auto-install":true,"latex-clean":true,"latex-min-runs":1,"latex-max-runs":10,"latex-makeindex":"makeindex","latex-makeindex-opts":[],"latex-tlmgr-opts":[],"latex-input-paths":[],"latex-output-dir":null,"link-external-icon":false,"link-external-newwindow":false,"self-contained-math":false,"format-resources":[],"notebook-links":true},"pandoc":{"standalone":true,"wrap":"none","default-image-extension":"png","to":"html","toc":true,"include-in-header":[{"text":"<link rel=\"stylesheet\" href=\"https://cdn.jsdelivr.net/gh/jpswalsh/academicons@1/css/academicons.min.css\">\n"}],"output-file":"projects.html"},"language":{"toc-title-document":"Table of contents","toc-title-website":"On this page","related-formats-title":"Other Formats","related-notebooks-title":"Notebooks","source-notebooks-prefix":"Source","other-links-title":"Other Links","code-links-title":"Code Links","launch-dev-container-title":"Launch Dev Container","launch-binder-title":"Launch Binder","article-notebook-label":"Article Notebook","notebook-preview-download":"Download Notebook","notebook-preview-download-src":"Download Source","notebook-preview-back":"Back to Article","manuscript-meca-bundle":"MECA Bundle","section-title-abstract":"Abstract","section-title-appendices":"Appendices","section-title-footnotes":"Footnotes","section-title-references":"References","section-title-reuse":"Reuse","section-title-copyright":"Copyright","section-title-citation":"Citation","appendix-attribution-cite-as":"For attribution, please cite this work as:","appendix-attribution-bibtex":"BibTeX citation:","appendix-view-license":"View License","title-block-author-single":"Author","title-block-author-plural":"Authors","title-block-affiliation-single":"Affiliation","title-block-affiliation-plural":"Affiliations","title-block-published":"Published","title-block-modified":"Modified","title-block-keywords":"Keywords","callout-tip-title":"Tip","callout-note-title":"Note","callout-warning-title":"Warning","callout-important-title":"Important","callout-caution-title":"Caution","code-summary":"Code","code-tools-menu-caption":"Code","code-tools-show-all-code":"Show All Code","code-tools-hide-all-code":"Hide All Code","code-tools-view-source":"View Source","code-tools-source-code":"Source Code","tools-share":"Share","tools-download":"Download","code-line":"Line","code-lines":"Lines","copy-button-tooltip":"Copy to Clipboard","copy-button-tooltip-success":"Copied!","repo-action-links-edit":"Edit this page","repo-action-links-source":"View source","repo-action-links-issue":"Report an issue","back-to-top":"Back to top","search-no-results-text":"No results","search-matching-documents-text":"matching documents","search-copy-link-title":"Copy link to search","search-hide-matches-text":"Hide additional matches","search-more-match-text":"more match in this document","search-more-matches-text":"more matches in this document","search-clear-button-title":"Clear","search-text-placeholder":"","search-detached-cancel-button-title":"Cancel","search-submit-button-title":"Submit","search-label":"Search","toggle-section":"Toggle section","toggle-sidebar":"Toggle sidebar navigation","toggle-dark-mode":"Toggle dark mode","toggle-reader-mode":"Toggle reader mode","toggle-navigation":"Toggle navigation","crossref-fig-title":"Figure","crossref-tbl-title":"Table","crossref-lst-title":"Listing","crossref-thm-title":"Theorem","crossref-lem-title":"Lemma","crossref-cor-title":"Corollary","crossref-prp-title":"Proposition","crossref-cnj-title":"Conjecture","crossref-def-title":"Definition","crossref-exm-title":"Example","crossref-exr-title":"Exercise","crossref-ch-prefix":"Chapter","crossref-apx-prefix":"Appendix","crossref-sec-prefix":"Section","crossref-eq-prefix":"Equation","crossref-lof-title":"List of Figures","crossref-lot-title":"List of Tables","crossref-lol-title":"List of Listings","environment-proof-title":"Proof","environment-remark-title":"Remark","environment-solution-title":"Solution","listing-page-order-by":"Order By","listing-page-order-by-default":"Default","listing-page-order-by-date-asc":"Oldest","listing-page-order-by-date-desc":"Newest","listing-page-order-by-number-desc":"High to Low","listing-page-order-by-number-asc":"Low to High","listing-page-field-date":"Date","listing-page-field-title":"Title","listing-page-field-description":"Description","listing-page-field-author":"Author","listing-page-field-filename":"File Name","listing-page-field-filemodified":"Modified","listing-page-field-subtitle":"Subtitle","listing-page-field-readingtime":"Reading Time","listing-page-field-wordcount":"Word Count","listing-page-field-categories":"Categories","listing-page-minutes-compact":"{0} min","listing-page-category-all":"All","listing-page-no-matches":"No matching items","listing-page-words":"{0} words","listing-page-filter":"Filter","draft":"Draft"},"metadata":{"lang":"en","fig-responsive":true,"quarto-version":"1.6.42","theme":"sandstone","backgroundcolor":"#ffffff","fontcolor":"#333333","linkcolor":"#558b2f","fontsize":"1.1em","linestretch":1.7,"mainfont":"Arial","monofont":"Arial","fontfamily":"Arial","maxwidth":"1200px","title":"Projects"},"extensions":{"book":{"multiFile":true}}}},"projectFormats":["html"]}